Samsara Therapeutics

About:

Samsara Therapeutics is a biopharmaceutical company that aims to discover therapeutics to treat rare genetic and neurodegenerative disease.

Website: http://samsaratherapeutics.com

Top Investors: FJ Labs, Cambrian Biopharma, Apollo Health Ventures, Korify Capital, Healthspan Capital

Description:

Samsara Therapeutics, Inc. is an R&D-stage biopharmaceutical platform company aiming to discover, develop and commercialize therapeutics for the treatment of unmet medical needs and age-related diseases. Samsara's platform is a pipeline for the identification, chemical optimization, and in vivo validation of compounds that extend a healthy lifespan.

Total Funding Amount:

$13.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)samsaratherapeutics.com

Founders:

Guido Kroemer, Sebastian Brunemeier

Number of Employees:

11-50

Last Funding Date:

2022-09-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai